about
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainImmune Mechanisms in Myelodysplastic SyndromeManagement of Pemphigus VulgarisTowards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapyTreatment-related progressive multifocal leukoencephalopathy: current understanding and future stepsMicro and nanoparticle drug delivery systems for preventing allotransplant rejectionHydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogsInosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr miceThe antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivoTacrolimus inhibits NF-κB activation in peripheral human T cellsTopical mycophenolate mofetil in the treatment of vitiligo: a pilot study.Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients.Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patientsPharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosusIdiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choicesRandomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease.Roles of the immune system in skin cancer.Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil.Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patientsTransient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity.Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosisFemale spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males.Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase.Mycophenolic acid derivative 118 improves outcome of skin grafts by suppressing IL-17 production.A review on therapeutic drug monitoring of immunosuppressant drugs.Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.Combination Immunotherapy for Type 1 Diabetes.A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasionNuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus.Active and Repressive Chromatin-Associated Proteome after MPA Treatment and the Role of Midkine in Epithelial Monolayer PermeabilityCorrelation of abnormal histology with endoscopic findings among mycophenolate mofetil treated patients.A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil.Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndromeSynergistic Inhibition of Tumor Necrosis Factor-Alpha-Stimulated Pro-Inflammatory Cytokine Expression in HaCaT Cells by a Combination of Rapamycin and Mycophenolic Acid.Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs.Internally ratiometric fluorescent sensors for evaluation of intracellular GTP levels and distribution.Pneumocystis Pneumonia in Solid-Organ Transplant Recipients.
P2860
Q24619923-0E122848-E804-4867-BD4E-C207D75A42BDQ26744500-CE57A478-7BDB-470D-B5ED-12E2AEA800C1Q26747092-E0F5D0E6-E3FC-445C-AB00-C4D01A668F7DQ26771159-C333DEE3-A3CD-4AE2-8F0C-DAE5FDE756A3Q26823444-BEC61EA9-67E9-4401-8BE9-B88328972B3BQ28080720-1A0967A3-378D-45CE-A8B0-BB1FC6B38390Q28343742-B7C92FC5-E029-4ECE-BB7F-2DEB46356782Q28344894-E8DBA899-2F94-4007-812A-966C13D07532Q28369328-DB03F12B-0E11-42F5-B045-E70A26BEE7FEQ28379426-0C8DD0B2-1F03-4709-9306-BAAD92799DAAQ28485897-4B9971CB-6E19-4FB8-B115-6875C24A26A7Q33655987-714B76D5-0A69-4F67-8394-5AED0497A067Q34077882-451B6253-ADF3-4B71-90F1-5F6AE504BC61Q34425701-FFEECD7A-287E-4045-97F1-2DC49DF15498Q34494943-2A117694-D87E-43CC-84DA-885B60364785Q35151856-E2824CEC-C233-4707-9051-2878C536DAD5Q35310520-96418F63-2CB3-434F-84D3-1C3A6AA575B6Q35403714-CAB28251-D78C-44FF-A07D-4A87AD86FF11Q35605432-D28928D7-6270-48AF-9026-35B58A8BECCCQ35825497-FA97291A-1114-4A12-8E98-C55A34ECBF37Q35827831-05A4A01B-36E6-4370-8D83-C1DC45FA2075Q36143384-71BB400D-BF4A-4EF8-A8E4-D0AA6C9C127EQ36288343-B2ECE7C2-3DD2-4DA3-854D-FCA3D69DC2E4Q37022001-EAD6AD26-2476-4C2C-AB13-4F9237285A30Q37174707-D7ED98A8-D10B-44A0-A160-016E35B25D59Q37638243-D8DC5E9B-6B3B-4D2C-B33E-07B88DC33B8EQ37728508-53E31C05-AEA3-4370-9A4B-EA4B018AFA8CQ38089593-C0F1714E-1EB4-48D9-86E9-3F370972938CQ38123696-3AA86168-907D-4184-9810-5681BAD1AC28Q38680333-7C61F3C9-D572-4F8B-B8EB-A0AB9678888AQ39076856-07C2548F-F4FB-4719-96C6-E46E7A2024A4Q39516173-F6B84D68-34EE-4770-8453-F58F1F6A61B2Q40753539-0B7B9290-073E-48B7-BFC6-21AAE0B6A28AQ41477460-A09DA08C-7147-43E8-97CB-BB86145F31E4Q41857320-047C461A-26B9-4DFF-BE14-74CB24FC9EE4Q42019934-2A124D1E-AC9F-4DEE-82ED-0116BAF397A9Q42066048-79E971F9-9651-45F4-8FA8-59C03D17897CQ43977140-709F0430-A3D9-475F-A803-F0AB0008C0BFQ47860154-D469D087-5379-45A8-AF42-5A21B362469EQ48149271-C939F68E-AAB9-4526-BF67-8F6688E3C60C
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Mechanism of action of mycophenolate mofetil.
@ast
Mechanism of action of mycophenolate mofetil.
@en
Mechanism of action of mycophenolate mofetil.
@nl
type
label
Mechanism of action of mycophenolate mofetil.
@ast
Mechanism of action of mycophenolate mofetil.
@en
Mechanism of action of mycophenolate mofetil.
@nl
prefLabel
Mechanism of action of mycophenolate mofetil.
@ast
Mechanism of action of mycophenolate mofetil.
@en
Mechanism of action of mycophenolate mofetil.
@nl
P1476
Mechanism of action of mycophenolate mofetil.
@en
P2093
J T Ransom
P304
P577
1995-12-01T00:00:00Z